Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
Novartis Pharmaceuticals
Reinhard Dummer; Axel Hauschild; Mario Santinami; Victoria Atkinson; Mario Mandalà; John M Kirkwood; Vanna Chiarion Sileni; James Larkin; Marta Nyakas; Caroline Dutriaux; Andrew Haydon; Caroline Robert; Laurent Mortier; Jacob Schachter; Thierry Lesimple; Ruth Plummer; Kohinoor Dasgupta; Eduard Gasal; Monique Tan; Georgina V Long; Dirk Schadendorf